TGen discovers potential drug targets to cut cancer pain
The Translational Genomics Research Institute (TGen) has discovered potential drug targets to reduce pain in pancreatic cancer patients. TGen researchers have found that the nerve growth factor (NGF), a neurotrophic factor, and…
